Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,64,954
Aug 08, 2025 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹255.45
₹-12.65 (-4.72%)
251.00Low
Today’s Performance
269.15High
139.90Low
52 Week’s Performance
328.04High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-4.72%
  • 1 Week-5.86%
  • 1 Month11.19%
  • 3 Months21.41%
  • 6 Months5.45%
  • 1 Year74.44%
  • 3 Years22.60%
  • 5 Years78.19%

bt_logoStock Summary

  • Face Value (₹)2.00
  • Beta1.62
  • 52-Week Low (₹)139.90
  • 52-Week High (₹)328.04
  • Price-to-Book (X)*7.06
  • Dividend Yield (%)0.98
  • Price-to-Earnings (P/E) (X)*27.84
  • Earnings Per Share (₹)9.14
  • Market Cap (₹ Cr.)*1,699.42
* Values as of last close price

bt_logoCOMPETITORS

BT TV

India’s Health Insurance Crisis: What’s Causing Mistrust & Why It Matters2:26India’s Health Insurance Crisis: What’s Causing Mistrust & Why It Matters
India’s Borrow-to-Spend Culture – Sanjay Kathuria On Good vs Bad Debt3:22India’s Borrow-To-Spend Culture – Sanjay Kathuria On Good Vs Bad Debt
McKinsey India's Rajat Dhawan: India’s Electric Mobility and Battery Demand to Grow 20x in 15 Years1:50McKinsey India's Rajat Dhawan: India’s Electric Mobility and Battery Demand to Grow 20x in 15 Years
The Good And Bad Of India’s EMI Culture – Sarthak Ahuja at India @1003:43The Good And Bad Of India’s EMI Culture – Sarthak Ahuja at India @100
Trump Tariffs Hit Indian Exports & MSMEs Hard: GTRI, FIEO | BT India@1004:05Trump Tariffs Hit Indian Exports & MSMEs Hard: GTRI, FIEO | BT India@100
Amitabh Chaudhry MD & CEO Axis Bank: No systemic NPA crisis expected in next 10-15 years2:14Amitabh Chaudhry MD & CEO Axis Bank: No Systemic NPA Crisis expected In Next 10-15 Years
Trump Tariffs To Hit 60% Of India’s Exports: FIEO, EY Leaders | BT India@1002:52Trump Tariffs To Hit 60% Of India’s Exports: FIEO, EY Leaders | BT India@100
Exclusive: DIPAM Secretary On The Impact Of Trump Tariffs On Disinvestment | BT India@1002:21Exclusive: DIPAM Secretary On The Impact Of Trump Tariffs On Disinvestment | BT India@100
Montek Ahluwalia Flags Risks of Linking Farm Reforms to Trade, Says Reforms Need Internal Consensus2:59Montek Ahluwalia Flags Risks Of Linking Farm Reforms To Trade, Says Reforms Need Internal Consensus
India’s Growth Potential & The Road Ahead | Neelkanth Mishra at India@1006:57India’s Growth Potential & The Road Ahead | Neelkanth Mishra at India@100
View more

bt_logoFAQ's

What was Jagsonpal Pharmaceuticals Ltd share price previously?
Jagsonpal Pharmaceuticals Ltd share price was down by -4.72% from the previous closing price of ₹268.10.
Who are peers of Jagsonpal Pharmaceuticals Ltd?
The peers of Jagsonpal Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Jagsonpal Pharmaceuticals Ltd?
The promotor/promotors of Jagsonpal Pharmaceuticals Ltd are Manish Gupta, Harsha Raghavan, Debasis Bikash Nandy, Radhika Dudhat, Pallavi Dinodia, Prithipal Singh Kochhar.
What has been 52-week high of Jagsonpal Pharmaceuticals Ltd stocks?
The highest price of Jagsonpal Pharmaceuticals Ltd stock is ₹328.04 in the last 52-week.
What is the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) today on NSE?
As on Aug 08, 2025 Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)’s share price on NSE is Rs 255.45
What is the market cap of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The current market capitalisation of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 1,699.42 crores
What is Jagsonpal Pharmaceuticals Ltd Share symbol?
The symbol of Jagsonpal Pharmaceuticals Ltd is JAGSNPHARM.
What is the PE ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The current PE ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 27.84.
What is the PB ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The current PB ratio of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 7.06.
Today’s High & Low share prices of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) on NSE?
Today, the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) on NSE touched a high of Rs 269.15 and a low of Rs 251
What price did Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) shares open on the NSE today?
On NSE, the share price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) opened at Rs 268.15
What is the 52-week high of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The 52-week high price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is Rs 328.04
What is the 52-week low of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)?
The 52-week low price of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is Rs 139.90

bt_logoAbout Jagsonpal Pharma

Jagsonpal Pharmaceuticals Ltd, incorporated in the year 1978, has its registered office in T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049, 91-011-46181100/46109900, 91-011-26498341. The main industry in which Jagsonpal Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Jagsonpal Pharmaceuticals Ltd is/are Walker Chandiok & Co LLP. In the main management, Harsha Raghavan is chairman and is the company secretary for Jagsonpal Pharmaceuticals Ltd.

  • MG
    Manish GuptaManaging Director
  • HR
    Harsha RaghavanChairman & Non Executive Director
  • DBN
    Debasis Bikash NandyIndependent Director
  • RD
    Radhika DudhatIndependent Director
  • PD
    Pallavi DinodiaIndependent Director
  • PSK
    Prithipal Singh KochharNon Executive Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.